3 Ways the Democratic Party's Platform Could Impact Biotech and Pharma Stocks if Implemented

With the Democratic Party's national convention now wrapped up in Chicago, it's a time of ambitious policy proposals that seek to win votes and reshape the face of the nation. The party's platform contains many proposals that could have profound implications for the biopharma industry and investors, covering ideas for changing everything from healthcare affordability to science investment, intellectual property, and even jobs training.So let's dive in and analyze what the Democratic Party is suggesting, and how it might affect the stocks you're holding or thinking of buying over the next few years.Limiting the prices of medicines is a key policy component of the party's healthcare platform. There are two proposed avenues for general pricing reform, and one additional avenue for diabetes care specifically.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool